ACYCLOVIR

Product NDC
70518-2496
11-digit product format
705182496
Labeler code
70518
Product ID
70518-2496_d04bf5bd-4aa8-ec42-e053-2995a90a42c8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
acyclovir
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA074889
Marketing category
ANDA
Marketing start
2019-12-18
Marketing end
0000-00-00
Substance
ACYCLOVIR
Active strength
200 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70518-2496-0EA - Each70518-24966935d872-d04a-4688-ac82-0663d66eebc612023-01-09
70518-2496-1EA - Each70518-249699eb62ee-8fb2-4cc8-a0bf-3fc73be9856c12023-01-09

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2496-07051824960030 CAPSULE in 1 BLISTER PACK (70518-2496-0) 30 capsule2019-12-180000-00-00NoNoCurrent
70518-2496-17051824960130 CAPSULE in 1 BLISTER PACK (70518-2496-1) 30 capsule2021-10-150000-00-00NoNoCurrent